
The episode discusses the advancements in treating IgA nephropathy, focusing on B-cell therapy and new therapeutic agents.
For decades, treating IgA nephropathy meant looking thoughtful while saying "let's optimise supportive care and monitor closely." Not anymore. We've gone from one road to a full therapeutic roundabout, and nobody wants the wrong exit. Hugo Diniz welcomes Vlado Perkovic to navigate the new era: anti-APRIL and anti-BAFF agents, the VISIONARY and ORIGIN data, and the 2025 KDIGO framework. Are we finally switching off the disease at its source, or just admiring another elegant proteinuria curve? ...
Explore listener stats, chart rankings, contacts and more on the A pinch of salt - A podcast by ERA podcast page.